Biotech fundraising is increasingly resembling traditional paths seen in software, with many funds showing interest in innovative science companies.

Successful biotech funds often incubate ideas internally before spinning them out as independent companies, which has proven effective in the industry.

Investing out of pity for founders rarely yields returns; focus on strong, capable founders instead.

There is a growing interest from early-stage technology investors in funding biotech companies, with many successfully raising significant seed funding.

You don't necessarily need a PhD to be a co-founder in biotech; personal motivation and understanding of the field can be just as valuable.

We encourage our team to invest in opportunities that show promise, even if they come with risks, as this can lead to significant breakthroughs. In venture capital, the key to success is identifying the next big thing early and investing heavily, rather than focusing on win rates or percentage returns.

Investing in startups should not just be about making a difference; you should also consider the potential for returns on your investment.

Invest in founders who have a strong track record and the capability to lead their companies effectively, even if the market is tough.

Biotech founders often make the mistake of not conducting the essential experiments needed to validate their ideas, fearing that failure could jeopardize their startups.